MO - Altria Group, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
48.84
+0.84 (+1.75%)
As of 12:01PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close48.00
Open48.11
Bid48.88 x 1000
Ask48.89 x 1200
Day's Range47.91 - 48.99
52 Week Range42.40 - 66.04
Volume3,610,969
Avg. Volume7,999,804
Market Cap91.376B
Beta (3Y Monthly)0.35
PE Ratio (TTM)14.89
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield3.20 (6.37%)
Ex-Dividend Date2019-06-13
1y Target EstN/A
Trade prices are not sourced from all markets
  • Altria’s Valuation Multiple Compared to Its Peers
    Market Realist2 hours ago

    Altria’s Valuation Multiple Compared to Its Peers

    As of June 21, Altria was trading at a forward PE ratio of 11.1x—compared to 12.8x before its first-quarter earnings were announced. Altria posted its first-quarter earnings on April 25.

  • Why Did Altria Stock Fall 4.5% on June 21?
    Market Realist3 hours ago

    Why Did Altria Stock Fall 4.5% on June 21?

    Scott Gottlieb’s comments might have led to a fall in Altria’s stock price on June 21. At the closing on June 21, the company was trading at $48.00—a fall of 4.5% from the previous day’s closing price.

  • Is Altria's Cigarette Price Hike Really the Bullish Sign Analysts Think?
    Motley Fool3 days ago

    Is Altria's Cigarette Price Hike Really the Bullish Sign Analysts Think?

    It may indicate a more troubling problem with sales.

  • Juul May Have Hard Time Getting E-Cig Approved, Ex-FDA Chief Says
    Bloomberg3 days ago

    Juul May Have Hard Time Getting E-Cig Approved, Ex-FDA Chief Says

    (Bloomberg) -- The former commissioner of the Food and Drug Administration said he thinks Juul Labs Inc. will have a difficult time getting its e-cigarette approved under rules that will eventually force makers of the devices to go through government review to keep selling to consumers.“Juul is going to be in a hard spot to ever get their product approved,” ex-Commissioner Scott Gottlieb, who stepped down from leading the agency earlier this year, said on CNBC Friday.Altria Group Inc., which sells Marlboro cigarettes, bought a $12.8 billion stake in Juul last year. Shares of the tobacco company closed down 4.5% to $48 in New York, the lowest closing price since Jan. 30.During his two-year tenure atop the FDA, Gottlieb initially took a cautious approach toward strictly regulating e-cigarettes, seeing them as a tool to help adult smokers quit. He evolved into a harsh critic, calling youth use an “epidemic” and said that Juul and other e-cigarettes had attracted previous nonsmokers.To respond to a lawsuit claiming the agency failed to sufficiently regulate the products, the FDA has proposed giving manufacturers 10 months to submit applications to keep selling the nicotine devices.Juul said it's working on its application to the FDA, which will include information on how the product can help existing smokers stop using cigarettes. ``We are confident adult smokers will not be left without a viable alternative to combustible cigarettes,'' said Juul spokesman Matt David.Juul is popular with many young and underage people, and public health advocates have said that the company specifically targeted younger users. The company has pulled back on some marketing activities and has taken steps to make sure its product reaches only people of appropriate age. Juul’s website says that “We don’t want anyone who doesn’t smoke, or already use nicotine, to use Juul products.”“We remain confident that Juul can successfully navigate the PMTA process,” Altria spokesman Steven Callahan said in an emailed statement. PMTA refers to the FDA’s premarket tobacco application rules. A federal judge said last month the FDA must speed up its implementation of the rules, though hasn’t made a final ruling on the agency’s proposal.A spokesman for the FDA didn’t immediately provide a comment.Government health officials are also researching the use of Juul as part of a regular survey that gauges youth tobacco use. The data they collect could have an impact on the likely review of the devices.“If we see a further increase in overall use, and respondents report to using Juul mostly, then we think whatever Juul says, and whatever actions they point to that they have implemented, it won’t matter,” Ryan Tomkins, a stock analyst with Jefferies, said in a note to clients Friday.(Adds Juul statement in sixth paragraph)\--With assistance from Janet Freund, Tiffany Kary and Anna Edney.To contact the reporter on this story: Drew Armstrong in New York at darmstrong17@bloomberg.netTo contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Timothy AnnettFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • These Billion-Dollar Pot Stocks Are Buyout Candidates
    Motley Fool3 days ago

    These Billion-Dollar Pot Stocks Are Buyout Candidates

    Three marijuana stocks worth more than $1 billion that look more like acquisition targets than acquirers.

  • Investing.com3 days ago

    Altria Falls 3%

    Investing.com - Altria (NYSE:MO) fell by 3.11% to trade at $48.68 by 12:04 (16:04 GMT) on Friday on the NYSE exchange.

  • 3 Cannabis Stocks With the Highest Dividend Yields
    Motley Fool4 days ago

    3 Cannabis Stocks With the Highest Dividend Yields

    Believe it or not, these cannabis stocks are profitable and pay really attractive dividends.

  • Motley Fool4 days ago

    E-Cigs Face Ruin as FDA Narrows Window to File Applications

    Judicial ruling raises again the possible collapse of the electronic cigarette industry.

  • Altria (MO) Stock Sinks As Market Gains: What You Should Know
    Zacks6 days ago

    Altria (MO) Stock Sinks As Market Gains: What You Should Know

    Altria (MO) closed the most recent trading day at $50.11, moving -1.47% from the previous trading session.

  • Is Altria Group, Inc.'s (NYSE:MO) 44% ROE Better Than Average?
    Simply Wall St.6 days ago

    Is Altria Group, Inc.'s (NYSE:MO) 44% ROE Better Than Average?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • Barrons.com7 days ago

    Marlboro Parent Altria Will Gain Along With the Price of Cigarettes, Analyst Says

    Wells Fargo argues that Altria’s recent price increases demonstrate the tobacco giant’s pricing power—and its ability to compete even in the face of e-cigarette popularity.

  • Latest Altria Acquisition Bolsters Its Smokeless Segment
    Motley Fool7 days ago

    Latest Altria Acquisition Bolsters Its Smokeless Segment

    The tobacco giant continues to diversify away from traditional cigarettes.

  • The 5 Most Profitable Pot Stocks on the Planet
    Motley Fool8 days ago

    The 5 Most Profitable Pot Stocks on the Planet

    Most cannabis companies are losing money. These aren't.

  • Barrons.com11 days ago

    Altria Stock Can Rise With the Company’s ‘Tremendous Pricing Power’

    An unexpected price increase for nearly all of the tobacco maker’s brands, emphasizes Altria’s pricing power and will be followed by the rest of the industry, Wells Fargo says.

  • Altria (MO) Dips More Than Broader Markets: What You Should Know
    Zacks12 days ago

    Altria (MO) Dips More Than Broader Markets: What You Should Know

    Altria (MO) closed at $51.61 in the latest trading session, marking a -1.04% move from the prior day.

  • The Zacks Analyst Blog Highlights: Intel, Altria, Stryker, Sherwin-Williams and Verisk
    Zacks12 days ago

    The Zacks Analyst Blog Highlights: Intel, Altria, Stryker, Sherwin-Williams and Verisk

    The Zacks Analyst Blog Highlights: Intel, Altria, Stryker, Sherwin-Williams and Verisk

  • Top Stock Reports for Intel, Altria & Stryker
    Zacks13 days ago

    Top Stock Reports for Intel, Altria & Stryker

    Top Stock Reports for Intel, Altria & Stryker

  • Why Much-Maligned Cronos Group Could Be a Sleeping Giant
    Motley Fool13 days ago

    Why Much-Maligned Cronos Group Could Be a Sleeping Giant

    While many are hating on Cronos Group, one analyst thinks the company is poised to be a big winner in the U.S.

  • The Most Hated Pot Stock Received a Rare Upgrade but Is Still Grossly Overvalued
    Motley Fool14 days ago

    The Most Hated Pot Stock Received a Rare Upgrade but Is Still Grossly Overvalued

    Bank of America sees 39% upside in this marijuana stock, but a lot would need to go right for that to happen.

  • 3 Top Marijuana Stocks to Watch in June
    Motley Fool16 days ago

    3 Top Marijuana Stocks to Watch in June

    With the industry possibly cooling off, here are the names to remember.

  • E-Cig Maker Juul Eyes Its Own Retail Store Chain
    Motley Fool19 days ago

    E-Cig Maker Juul Eyes Its Own Retail Store Chain

    Concerns over teen e-cig usage drives industry leader to assert greater control over access.

  • Barrons.com19 days ago

    Marijuana Stock Cronos Group Soars as Analyst Goes From Sell to Buy

    Cronos Group stock was rising thanks to a two-notch upgrade from Bank of America Merrill Lynch, which argues that a move into the U.S. CBD market could be a huge opportunity for the company.

  • Barrons.com19 days ago

    Altria Stock Could Rise as It Mixes Marijuana With Its Tobacco Business

    Altria stock hasn’t performed well this year, but Wells Fargo believes there’s still a bull case to be made for the stock, especially given the company’s valuable partnership with marijuana company Cronos Group.

  • Investing.com19 days ago

    Pot Stock Cronos Higher After Upgrade

    Analysts Christopher Carey cited the prospect of the Canadian-based company expanding into the U.S. market as the reason for the upgrade.